QIAGEN and Whatman have a non-exclusive distribution partnership that provides QIAGEN with the right to market and sell Whatman FTA® and FTA-based kits to all QIAGEN's target markets including life ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Four US bidders, including General Electric, and Danaher, are vying to win control of Whatman, the laboratory ...
Out with the old and in with the new. Progress. Change. These ideas come to mind when one first encounters the BugStopper™, a new product from Whatman, Inc. Offered as a high tech replacement for the ...
WHATMAN, one of Kent's oldest businesses, is being sold for £363 million, it has been revealed. GE Healthcare, the UK-based subsidiary of American company General Electric, has agreed to buy the ...
Transaction marks GE Healthcare’s first acquisition attempt within its life science business since the failed buyout of Abbott units. GE Healthcare agreed to acquire Whatman for approximately $716.27 ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bob Thian, who joined last year’s failed shareholder revolt at SkyePharma, has appointed his fourth chief ...
Shares in Whatman jumped nearly 10% yesterday after GE Healthcare confirmed plans to buy the group in an all-cash deal for 270 pence a share, valuing the UK firm at around £363 million. Shares in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results